# Bombay Drug House Private Limited · 66-66 · INDIA — FDA import alert red lists: firms subject to detention without physical examination

For Bombay Drug House Private Limited · 66-66 · INDIA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is INDIA; product is Albuterol Sulfate; product code is 63 B - S 02 Albuterol Sulfate (Bronchodilator), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Kandivli , Akurli Road , Mumbai, Maharashtra INDIA, verified against its source on 2026-09-16.

- **Firm:** Bombay Drug House Private Limited _(verified: appears in the quote below)_
- **Import alert:** 66-66
- **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- **Country:** INDIA _(verified: appears in the quote below)_
- **Address:** Kandivli , Akurli Road , Mumbai, Maharashtra INDIA _(verified: appears in the quote below)_
- **Date published:** 09/30/2009 _(verified: appears in the quote below)_
- **Product code:** 63 B - S 02 Albuterol Sulfate (Bronchodilator), Active Pharm Ingred/Chems for Further Manuf _(verified: appears in the quote below)_
- **Product:** Albuterol Sulfate _(verified: appears in the quote below)_
- **FDA notes:** 10/3/2000 _(verified: appears in the quote below)_

## What the source says

> Bombay Drug House Private Limited Date Published : 09/30/2009 Kandivli , Akurli Road , Mumbai, Maharashtra INDIA 63 B - S 02 Albuterol Sulfate (Bronchodilator), Active Pharm Ingred/Chems for Further Manuf Date Published: 10/10/2018 Desc: Albuterol Sulfate Notes: 10/3/2000

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).